Improving Dysregulated Neural Networks With EEG-neurofeedback
Enrolling by invitationNot applicableNCT06587919
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Comorbid PTSD in the context of chronic pain rehabilitation is a major problem. The lack of effective and efficient methods that can be integrated into current practice is needed. The current recommended treatments for PTSD leave room for supplementary approaches to achieve symptom reduction. PTSD is characterized by specific alterations of neural activity, and the DMN is known to be involved in this. Neurofeedback is the most current approach to altering neural activity patterns towards a norm pattern found in healthy subjects. The aim of the present study is to assess whether EEG neurofeedback compared to an active control group receiving EEG sham neurofeedback is effective in alleviating PTSD symptoms and pain intensity in patients with chronic pain and comorbid PTSD after MVCs.
Study details
- Official title
- Improving Dysregulated Neural Networks With EEG-neurofeedback - A Randomized Placebo-Controlled Study
- Conditions
- Interventions
- Device: Neurofeedback
- Sponsor
- University of Southern Denmark
- Collaborators
- Imaging future
- Start date
- 2024-09-23
- Primary completion
- 2025-09-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Denmark
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * has finished treatment at Smertecenter Syd. * is still experiencing pain of more than 4 on the Numeric Ranking Scale (NRS). * has been exposed to an adverse event that causes continued arousal according to the International Trauma Questionnaire. Exclusion Criteria: * Participants with known neurological disorders will be excluded from participation.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06587919